The purpose of this study was to retrospectively explore the relationship between human epidermal growth factor receptor 2 ( HER2 ) messenger RNA ( mRNA ) expression and efficacy in patients receiving trastuzumab plus docetaxel ( HT ) or trastuzumab emtansine ( T-DM1 ) .